| Target Price | $387.60 |
| Price | $277.46 |
| Potential | 39.70% |
| Number of Estimates | 34 |
| 34 Analysts have issued a price target Lam Research 2027 . The average Lam Research target price is $387.60. This is 39.70% higher than the current stock price. The highest price target is $525.00 89.22% , the lowest is $215.13 22.46% . | |
| A rating was issued by 41 analysts: 35 Analysts recommend Lam Research to buy, 6 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Lam Research stock has an average upside potential 2027 of 39.70% . Most analysts recommend the Lam Research stock at Purchase. |
37 Analysts have issued a sales forecast Lam Research 2027 . The average Lam Research sales estimate is
. This is than the revenue of the last 12 months(TTM). The highest sales forecast is , the lowest is .This results in the following potential growth metrics:
25 Analysts have issued an Lam Research EBITDA forecast 2027. The average Lam Research EBITDA estimate is
. This is than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is , the lowest is .This results in the following potential growth metrics and future EBITDA Margins:
37 Lam Research Analysts have issued a net profit forecast 2027. The average Lam Research net profit estimate is
. This is than the net profit for the last 12 months(TTM). The highest net profit forecast is , the lowest is .This results in the following potential growth metrics and future Net Margins:
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Morgan Stanley |
Overweight
➜
Overweight
|
Unchanged | Oct 05 2026 |
| B. Riley Securities |
Buy
➜
Buy
|
Unchanged | Oct 01 2026 |
| UBS |
Buy
➜
Buy
|
Unchanged | Sep 01 2026 |
| Mizuho |
Outperform
➜
Outperform
|
Unchanged | Aug 25 2026 |
| Morgan Stanley |
Overweight
➜
Overweight
|
Unchanged | Jul 30 2026 |
| B. Riley Securities |
Buy
➜
Buy
|
Unchanged | Jul 30 2026 |
| Jefferies |
Buy
➜
Buy
|
Unchanged | Jul 30 2026 |
| Analyst Rating | Date |
|---|---|
|
Unchanged
Morgan Stanley:
Overweight
➜
Overweight
|
Oct 05 2026 |
|
Unchanged
B. Riley Securities:
Buy
➜
Buy
|
Oct 01 2026 |
|
Unchanged
UBS:
Buy
➜
Buy
|
Sep 01 2026 |
|
Unchanged
Mizuho:
Outperform
➜
Outperform
|
Aug 25 2026 |
|
Unchanged
Morgan Stanley:
Overweight
➜
Overweight
|
Jul 30 2026 |
|
Unchanged
B. Riley Securities:
Buy
➜
Buy
|
Jul 30 2026 |
|
Unchanged
Jefferies:
Buy
➜
Buy
|
Jul 30 2026 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


